August 9, 2016 / 2:02 PM / a year ago

BRIEF-Valeant seeking to modify lender agreements - CEO

Aug 9 (Reuters) - Valeant Pharmaceuticals comments from slide presentation and conference call:

* Repaid $1.29 bln debt as of Aug. 9; committed to minimum paydown $1.7 bln in 2016

* Core asset sales to reduce debt by more than $5 billion over 18 months

* Valeant CEO says in company is in compliance with bank debt maintenance covenants through 2016 but cushion not as large as he would like

* Core businesses, geographies that represent more than $2 billion revenue

* Valeant says has engaged banks and advisors in review of strategic alternatives; excludes core assets Further company coverage: (Reporting By Rod Nickel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below